Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.938 |
16 |
|
2005 |
2020 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
14 |
|
2014 |
2020 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
14 |
|
2005 |
2020 |
Brain Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
1018
|
204
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Drug abuse
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
405
|
39
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Lung Neoplasms
|
group |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1486
|
39
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Parasitic Diseases
|
group |
Infections
|
Disease or Syndrome
|
164
|
2
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Malignant neoplasm of mouth
|
group |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
756
|
184
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
AIDS-related malignancies
|
group |
Neoplasms; Infections; Immune System Diseases
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.050 |
None |
1.000 |
5 |
|
2017 |
2018 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.310 |
None |
1.000 |
2 |
|
2009 |
2018 |
Contact hypersensitivity
|
phenotype |
Skin and Connective Tissue Diseases
|
Pathologic Function
|
71
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Recurrent tumor
|
phenotype |
|
Neoplastic Process
|
735
|
33
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
< 0.001 |
1 |
|
2015 |
2015 |
Liver regeneration disorder
|
phenotype |
Digestive System Diseases
|
Disease or Syndrome
|
346
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Brain Edema
|
phenotype |
Nervous System Diseases
|
Pathologic Function
|
30
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Epileptic Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
250
|
7
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.040 |
None |
1.000 |
4 |
|
2015 |
2020 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.040 |
None |
1.000 |
4 |
|
2015 |
2020 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.040 |
None |
1.000 |
4 |
|
2013 |
2019 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.030 |
None |
1.000 |
3 |
|
2016 |
2018 |
Adult Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2528
|
98
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2020 |
Childhood Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2527
|
98
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2020 |